Clinical Trial Update: Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention [NA]

View source ↗

Summary

This clinical trial update reports on blood endothelium biomarkers for predicting major adverse cardiovascular events after percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Atherosclerosis, Percutaneous Coronary Intervention | NA | Status: COMPLETED